Galectin Therapeutics (GALT) Agrees to Sell 1.5M Convertible Preferred Shares
Tweet Send to a Friend
Galectin Therapeutics (NASDAQ: GALT) disclosed that on September 22, 2016 it entered into a Securities Purchase Agreement with 10X Fund ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
